Abstract
IMPORTANCE The incidence of hepatoblastoma is increasing, and liver transplant (LT) provides a potential cure for pediatric patients with unresectable hepatoblastoma; however, the use of LT for hepatoblastoma has not been examined in a modern cohort. Moreover, data are lacking on the association between the type of surgical management received and overall risk of death among pediatric patients with hepatoblastoma.
[mks_button size=”large” title=”Download PDF” style=”squared” url=”https://clinicalhealthjournal.com/wp-content/uploads/2020/09/Assessment-of-Survival-of-Pediatric-Patients-With.pdf” target=”_self” bg_color=”#000000″ txt_color=”#FFFFFF” icon=”” icon_type=”” nofollow=”0″]
Assessment-of-Survival-of-Pediatric-Patients-With
